logo







Home>Companies>Vaxcyte-nas-pcvx


Vaxcyte (nas: pcvx)

Vaxcyte (nas: pcvx)



Vaxcyte (NAS: PCVX) is a biotechnology company focused on enhancing global health through the development of innovative vaccines targeting prevalent and life-threatening diseases.
Sign up today to get real-time market insights on Vaxcyte (nas: pcvx) and hundreds of other pre-IPO companies



Vaxcyte (nas: pcvx) Overview

San Carlos, CA, United States
2013
Healthcare/Wellness
https://www.vaxcyte.com



Vaxcyte (nas: pcvx) Live Market Data

$00000000
$00000000




Vaxcyte (nas: pcvx) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO6/12/2020
Series D3/26/2020
Series C5/19/2018
Series B3/21/2017
Series A7/23/2015




Vaxcyte (nas: pcvx) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
TPG (NAS: TPG)Series D, Series CSeries D (2020-03-26)
Janus Henderson Investors (NYS: JHG)Series DSeries D (2020-03-26)




Vaxcyte (nas: pcvx) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Vaxcyte (nas: pcvx) data




Vaxcyte (nas: pcvx) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Vaxcyte (nas: pcvx) data




Latest Vaxcyte (nas: pcvx) News



Taking A Shot At Vaxcyte
RTTNewsOctober 13, 2024




Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.